236 related articles for article (PubMed ID: 36898085)
21. Mediastinal lymphomas: primary mediastinal (thymic) large B-cell lymphoma versus classical Hodgkin lymphoma, histopathologic dilemma solved?
Pervez S; Khawaja RD
Pathol Res Pract; 2010 Jun; 206(6):365-7. PubMed ID: 20185248
[TBL] [Abstract][Full Text] [Related]
22. Pembrolizumab in the treatment of refractory primary mediastinal large B-cell lymphoma: safety and efficacy.
Camus V; Bigenwald C; Ribrag V; Lazarovici J; Jardin F; Sarkozy C
Expert Rev Anticancer Ther; 2021 Sep; 21(9):941-956. PubMed ID: 34233557
[No Abstract] [Full Text] [Related]
23. How I manage patients with grey zone lymphoma.
Kritharis A; Pilichowska M; Evens AM
Br J Haematol; 2016 Aug; 174(3):345-50. PubMed ID: 27301470
[TBL] [Abstract][Full Text] [Related]
24. Gray zone lymphoma: chromosomal aberrations with immunophenotypic and clinical correlations.
Eberle FC; Salaverria I; Steidl C; Summers TA; Pittaluga S; Neriah SB; Rodriguez-Canales J; Xi L; Ylaya K; Liewehr D; Dunleavy K; Wilson WH; Hewitt SM; Raffeld M; Gascoyne RD; Siebert R; Jaffe ES
Mod Pathol; 2011 Dec; 24(12):1586-97. PubMed ID: 21822207
[TBL] [Abstract][Full Text] [Related]
25. The microenvironmental niche in classic Hodgkin lymphoma is enriched for CTLA-4-positive T cells that are PD-1-negative.
Patel SS; Weirather JL; Lipschitz M; Lako A; Chen PH; Griffin GK; Armand P; Shipp MA; Rodig SJ
Blood; 2019 Dec; 134(23):2059-2069. PubMed ID: 31697809
[TBL] [Abstract][Full Text] [Related]
26. PD-1-PD-L1 immune-checkpoint blockade in B-cell lymphomas.
Goodman A; Patel SP; Kurzrock R
Nat Rev Clin Oncol; 2017 Apr; 14(4):203-220. PubMed ID: 27805626
[TBL] [Abstract][Full Text] [Related]
27. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
Tao Y; Chen H; Liu D; Dai X
Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
[TBL] [Abstract][Full Text] [Related]
28. KLF4 is a tumor suppressor in B-cell non-Hodgkin lymphoma and in classic Hodgkin lymphoma.
Guan H; Xie L; Leithäuser F; Flossbach L; Möller P; Wirth T; Ushmorov A
Blood; 2010 Sep; 116(9):1469-78. PubMed ID: 20519630
[TBL] [Abstract][Full Text] [Related]
29. U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.
Sambade C; Berglund M; Lagercrantz S; Sällström J; Reis RM; Enblad G; Glimelius B; Sundström C
Int J Cancer; 2006 Feb; 118(3):555-63. PubMed ID: 16106419
[TBL] [Abstract][Full Text] [Related]
30. Aberrant expression of the dendritic cell marker TNFAIP2 by the malignant cells of Hodgkin lymphoma and primary mediastinal large B-cell lymphoma distinguishes these tumor types from morphologically and phenotypically similar lymphomas.
Kondratiev S; Duraisamy S; Unitt CL; Green MR; Pinkus GS; Shipp MA; Kutok JL; Drapkin RI; Rodig SJ
Am J Surg Pathol; 2011 Oct; 35(10):1531-9. PubMed ID: 21921781
[TBL] [Abstract][Full Text] [Related]
31. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.
Chapuy B; Stewart C; Dunford AJ; Kim J; Wienand K; Kamburov A; Griffin GK; Chen PH; Lako A; Redd RA; Cote CM; Ducar MD; Thorner AR; Rodig SJ; Getz G; Shipp MA
Blood; 2019 Dec; 134(26):2369-2382. PubMed ID: 31697821
[TBL] [Abstract][Full Text] [Related]
32. [Unclassified B-cell lymphomas with "grey zone" characteristics].
Chen DB; Shen DH
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):278-81. PubMed ID: 21616011
[No Abstract] [Full Text] [Related]
33. [Mediastinal lymphomas: histopathology].
Chetaille B
Rev Pneumol Clin; 2010 Feb; 66(1):28-31. PubMed ID: 20207293
[TBL] [Abstract][Full Text] [Related]
34. Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma.
Calvo KR; Traverse-Glehen A; Pittaluga S; Jaffe ES
Adv Anat Pathol; 2004 Sep; 11(5):227-38. PubMed ID: 15322489
[TBL] [Abstract][Full Text] [Related]
35. Single-cell profiling reveals the importance of CXCL13/CXCR5 axis biology in lymphocyte-rich classic Hodgkin lymphoma.
Aoki T; Chong LC; Takata K; Milne K; Marshall A; Chavez EA; Miyata-Takata T; Ben-Neriah S; Unrau D; Telenius A; Boyle M; Weng AP; Savage KJ; Scott DW; Farinha P; Shah SP; Nelson BH; Steidl C
Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34615710
[TBL] [Abstract][Full Text] [Related]
36. Targeted Mutational Profiling Reveals Clonal Relationships in Metachronous Occurrence of Classic Hodgkin and Mediastinal Large B-Cell Lymphomas.
Singh K; Lezama LS; Kurzer J; Oak J; Schultz LM; Walkush A; Cheng TC; Chen EH; May WA; Chang C; Link MP; Advani RH; Suarez CJ; Natkunam Y
Am J Surg Pathol; 2023 Jan; 47(1):81-90. PubMed ID: 36001451
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a description of 10 cases.
Gualco G; Natkunam Y; Bacchi CE
Mod Pathol; 2012 May; 25(5):661-74. PubMed ID: 22222636
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological analysis of immunohistochemical expression of immune checkpoint molecules in follicular lymphoma.
Yanagida E; Miyoshi H; Takeuchi M; Shimono J; Nakashima K; Yamada K; Kawamoto K; Moritsubo M; Shimasaki Y; Inoue K; Imamoto T; Furuta T; Kohno K; Ohshima K
Hematol Oncol; 2022 Oct; 40(4):530-540. PubMed ID: 35122292
[TBL] [Abstract][Full Text] [Related]
39. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
40. Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma.
Godfrey J; Mei M; Chen L; Song JY; Bedell V; Budde E; Armenian S; Puverel S; Nikolaenko L; Chen R; Daniels S; Kennedy N; Peters L; Rosen ST; Forman SJ; Popplewell LL; Kwak LW; Herrera AF
Haematologica; 2024 Feb; 109(2):533-542. PubMed ID: 37470137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
